Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Synageva BioPharma Corp GEVA

Healthcare Biotechnology
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:GEVA)

Alexion Completes Acquisition of Synageva

Business Wire June 23, 2015

Synageva BioPharma Completes Targeted Enrollment in Phase 1/2 Trial with SBC-103 for Mucopolysaccharidosis IIIB

PR Newswire June 4, 2015

SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of Synageva BioPharma Corp.

Business Wire June 2, 2015

Synageva BioPharma Submits Kanuma(TM) (Sebelipase Alfa) Application For LAL Deficiency In Japan

PR Newswire May 26, 2015

SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of Synageva BioPharma Corp. -GEVA

PR Newswire May 22, 2015

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Synageva BioPharma Corp. of Commencement of an Investigation In Connection With the Fairness of the Sale of the Company to Alexion Pharmaceuticals, Inc. -- GEVA

PR Newswire May 18, 2015

SYNAGEVA BIOPHARMA CORP. INVESTOR ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Synageva BioPharma Corp. Over the Proposed Sale of the Company to Alexion Pharmaceuticals, Inc.

Business Wire May 18, 2015

SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Synageva BioPharma Corp. And Encourages Investors To Contact The Firm For Additional Information

Business Wire May 13, 2015

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Synageva BioPharma Corp. of Commencement of an Investigation in Connection with the Fairness of the Sale of the Company to Alexion Pharmaceuticals, Inc.

Business Wire May 12, 2015
View More News ››

Opinion & Analysis (NDAQ:GEVA)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:GEVA)

Support test 3

please delete
concierge - November 1, 2017

Support test 2

please delete
concierge - November 1, 2017

Support test

please delete
concierge - November 1, 2017

.................

drjekyl - July 6, 2016

Sanj Patel

you are the luckiest man alive!  good on you for executing a transaction with Alexion for $8.2 billion that is an incredible...
drjekyl - May 6, 2015

I guess this is relevant!

i really enjoy listening to what SP has to say in all of his presentations. what i find particularly enjoyable is that they state in...
drjekyl - February 25, 2015
View more Bullboard ››

Liberty Defense Holdings Ltd.

Liberty Defense Holdings Ltd.

Liberty Defense provides multi-technology security solutions for concealed weapons detection in high volume foot traffic ...
View More »